[1]
Sandomenico, A.; Ruvo, M. Targeting Nodal and Cripto-1: perspectives inside dual potential theranostic cancer biomarkers. Curr. Med. Chem., 2019, 26(11), 1994-2050.
[2]
Squeglia, F.; Bachert, B.; De Simone, A.; Lukomski, S.; Berisio, R. The crystal structure of the streptococcal collagen-like protein 2 globular domain from invasive M3-type group A Streptococcus shows significant similarity to immunomodulatory HIV protein gp41. J. Biol. Chem., 2014, 289(8), 5122-5133.
[3]
Lukomski, S.; Bachert, B.A.; Squeglia, F.; Berisio, R. Collagen-like proteins of pathogenic streptococci. Mol. Microbiol., 2017, 103(6), 919-930.
[4]
McNitt, D.H.; Van De Water, L.; Marasco, D.; Berisio, R.; Lukomski, S. Streptococcal collagen-like protein 1 binds wound fibronectin: Implications in pathogen targeting. Curr. Med. Chem., 2019, 26(11), 1933-1945.
[5]
Esposito, C.; Pethoukov, M.V.; Svergun, D.I.; Ruggiero, A.; Pedone, C.; Pedone, E.; Berisio, R. Evidence for an elongated dimeric structure of heparin-binding hemagglutinin from Mycobacterium tuberculosis. J. Bacteriol., 2008, 190(13), 4749-4753.
[6]
Squeglia, F.; Ruggiero, A.; De Simone, A.; Berisio, R. A structural overview of mycobacterial adhesins: Key biomarkers for diagnostics and therapeutics. Protein Sci., 2018, 27(2), 369-380.
[7]
Squeglia, F.; Ruggiero, A.; Berisio, R. Chemistry of peptidoglycan in Mycobacterium tuberculosis life cycle: An off-the-wall balance of synthesis and degradation. Chemistry, 2018, 24(11), 2533-2546.
[8]
De Maio, F.; Squeglia, F.; Goletti, D.; Delogu, G. The mycobacterial surface protein HBHA: A promising biomarker for tuberculosis. Curr. Med. Chem., 2019, 26(11), 2051-2060.
[9]
Larrouy-Maumus, G. Lipids as biomarkers of cancer and bacterial infections. Curr. Med. Chem., 2019, 26(11), 1924-1932.
[10]
Phan, L.M.T.; Tufa, L.T.; Kim, H.J.; Lee, J.; Park, T.J. Trends in diagnosis for active tuberculosis using nanomaterials. Curr. Med. Chem., 2019, 26(11), 1946-1959.
Current Medicinal Chemistry
Title:Molecular Biomarkers of Disease for Diagnosis and Drug Development
Volume: 26 Issue: 11
Author(s): Rita Berisio
Affiliation:
Export Options
About this article
Cite this article as:
Berisio Rita , Molecular Biomarkers of Disease for Diagnosis and Drug Development, Current Medicinal Chemistry 2019; 26 (11) . https://dx.doi.org/10.2174/092986732611190628090938
DOI https://dx.doi.org/10.2174/092986732611190628090938 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nitric Oxide: State of the Art in Drug Design
Current Medicinal Chemistry Formulation of Nanoparticles Against TB - A Review
Recent Patents on Inflammation & Allergy Drug Discovery Pharmacogenetic Polymorphisms in a Portuguese Gypsy Population
Current Pharmacogenomics and Personalized Medicine Oxidative Stress and Antioxidant Potential of One Hundred Medicinal Plants
Current Topics in Medicinal Chemistry New Plates for Different Types of Plate Heat Exchangers
Recent Patents on Mechanical Engineering Trypanocidal Activity of Nitroaromatic Prodrugs: Current Treatments and Future Perspectives
Current Topics in Medicinal Chemistry HtrA Protease Family as Therapeutic Targets
Current Pharmaceutical Design Targeted Vaccine Adjuvants Based on Modified Cholera Toxin
Current Molecular Medicine miR-202 Mediates Metabolic Shift in Lung Cancer Cells via Targeting HK2
Current Signal Transduction Therapy Targeting Folate Metabolism in the Human Malaria Parasite Plasmodium falciparum
Current Enzyme Inhibition MDR/XDRTB: What are the New Treatment Options?
Current Respiratory Medicine Reviews Overview of Coumarins and its Derivatives: Synthesis and Biological Activity
Letters in Organic Chemistry Drug Targets from Human Pathogenic Amoebas: Entamoeba histolytica,Acanthamoeba polyphaga and Naegleria fowleri
Infectious Disorders - Drug Targets Steroid Hybrid Systems: New Molecular Entities with Potential Therapeutical Spectrum
Current Drug Therapy Novel Approach to the Role of NMDA Receptors in Traumatic Brain Injury
CNS & Neurological Disorders - Drug Targets Antimicrobial Peptides with pH-Dependent Activity and Alkaline Optima: Their Origins, Mechanisms of Action and Potential Applications
Current Protein & Peptide Science Concurrence of Talaromycosis and Kaposi Sarcoma in an HIV-Infected Patient: A Case Report
Current HIV Research Iminosugars and Relatives as Antiviral and Potential Anti-infective Agents
Current Topics in Medicinal Chemistry Gene Cloning and Homology Modeling of the 3-Oxoacyl-ACP Synthase from Aeromonas hydrophila for Drug Discovery
Letters in Drug Design & Discovery HIV-Specific T Cells: Strategies for Fighting a Moving Target
Current HIV Research